Subscribe to the FT to read:
Financial TimesCelgene to buy Impact Biomedicines for $1.1bn upfront
Make informed decisions with the FT.
Keep abreast of significant corporate, financial and political developments around the world. Stay informed and spot emerging risks and opportunities with independent global reporting, expert commentary and analysis you can trust.
Choose the subscription that is right for you
Not sure which package to choose? Try full access for 4 weeks